TWO SIGMA INVESTMENTS, LP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1179392
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,019,775
+$8,022,675 QoQ
Shares Held
271,228
+124.8% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99.33635170410135.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6636482958986535.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in SUPN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,019,775 | 271,228 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,997,100 | 120,666 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,328,673 | 257,976 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,806,253 | 57,305 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,184,086 | 97,224 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $903,529 | 24,987 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,636,799 | 84,567 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,299,006 | 48,561 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $799,947 | 23,452 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,636,991 | 194,782 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,848,044 | 67,031 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,732,213 | 257,226 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,564,968 | 208,804 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,944,468 | 138,617 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,488,174 | 103,048 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $594,332 | 18,389 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $1,188,247 | 38,592 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,554,608 | 250,367 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,465,494 | 58,247 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $7,005,015 | 294,948 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,723,246 | 206,962 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||